Skip to main content
. 2018 Oct 15;10(10):3276–3290.

Table 2.

The rat body weights and levels of proteinuria, serum UA, BUN, and creatinine before and after treatment with GTPs

Group 4 w 8 w 12 w
Body weight Sham 50.00 ± 10.00 73.57 ± 20.14 101.67 ± 18.92
RK 35.71 ± 6.34a 49.28 ± 8.38a 71.00 ± 11.40a
RK + OA 24.00 ± 6.48a,b 25.71 ± 7.86a,b 48.57 ± 16.51a,b
RK + OA + Tea low dose 25.00 ± 5.77a,b,c 41.00 ± 7.07a,c 66.00 ± 5.70a,c
RK + OA + Tea high dose 28.00 ± 6.89a,b,c 52.87 ± 9.35a,c 69.34 ± 3.67a,c
RK + OA + AP 16.25 ± 6.29a,b,c 39.33 ± 8.75a,c 65.00 ± 10.36a,c
Proteinuria Sham 3.12 ± 1.06 3.10 ± 1.00 3.16 ± 0.95
RK 5.31 ± 1.72a 7.13 ± 1.21a 7.64 ± 1.61a
RK + OA 8.40 ± 2.05a,b 9.49 ± 1.55a,b 5.58 ± 1.29a,b
RK + OA + Tea low dose 5.42 ± 1.49a,c,d 4.26 ± 1.04b,c 5.13 ± 1.44a,b
RK + OA + Tea high dose 5.25 ± 1.34a,c,d 4.15 ± 0.87b,c 4.64 ± 1.05a,b
RK + OA + AP 7.77 ± 2.26a,b 5.72 ± 1.57a,c 5.59 ± 1.79a
Serum UA Sham 87.10 ± 23.06 87.60 ± 21.30 86.93 ± 20.63
RK 87.88 ± 28.49 102.55 ± 22.52 77.66 ± 20.75
RK + OA 206.10 ± 59.15a,b 226.48 ± 36.89a,b 195.88 ± 51.67a,b
RK + OA + Tea low dose 180.82 ± 38.04a,b 153.96 ± 31.52a,b,c 143.38 ± 36.68a,b,c
RK + OA + Tea high dose 175.35 ± 34.16a,b 137.58 ± 28.18a,b,c 130.74 ± 40.34a,b,c
RK + OA + AP 154.24 ± 28.55a,b,c 147.95 ± 25.27a,b,c 135.05 ± 33.80a,b,c
BUN Sham 5.34 ± 1.40 5.31 ± 1.32 5.27 ± 1.46
RK 8.77 ± 1.25a 10.74 ± 1.08a 12.13 ± 1.48a
RK + OA 11.66 ± 0.91a,b 13.06 ± 2.72a,b 15.72 ± 4.43a,b
RK + OA + Tea 12.64 ± 2.23a,b 9.44 ± 1.38a,c,d 9.54 ± 1.53a,c
RK + OA + AP 12.28 ± 3.77a,b 13.37 ± 1.58a,b 11.18 ± 2.15a,c
Creatinine Sham 52.36 ± 11.75 52.36 ± 10.77 57.85 ± 9.81
RK 68.03 ± 12.56a 70.05 ± 9.07a 78.20 ± 13.73a
RK + OA 88.10 ± 15.15a,b 93.15 ± 16.42a,b 102.30 ± 20.15a,b
RK + OA + Tea 87.32 ± 10.74a,b 73.25 ± 10.93a,c 66.13 ± 9.62c,d
RK + OA + AP 97.64 ± 7.33a,b 75.33 ± 12.81a,c 83.48 ± 10.59a,c
a

P < 0.05 vs. Sham;

b

P < 0.05 vs. RK;

c

P < 0.05 vs. RK + OA;

d

P < 0.05 vs. RK + OA + AP.

AP: allopurinol.